RegeniSource
RegeniSource is a Service Disabled Veteran Owned Small Business (SDVOSB) medical implant distributor in San Antonio, TX, distributing regenerative biologics and medical devices from ten-plus manufacturers to military, VA hospitals, and private healthcare providers.
- Company typePrivate
- Founded-
- HeadquartersSan Antonio, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What RegeniSource does
RegeniSource, LLC is a Service Disabled Veteran Owned Small Business (SDVOSB) headquartered in San Antonio, Texas that operates as a medical implant distributor rather than a product developer. The company distributes regenerative medicine products — including allograft bone, platelet-rich plasma (PRP) systems, bone marrow concentrate (BMC) devices, fish skin grafts, amniotic allografts, decellularized dermal grafts, sterile surgical tourniquets, and electrospun synthetic wound care matrices — sourced from at least ten manufacturers including CellRight Technologies, EmCyte Corporation, Kerecis, PainTEQ, RenovoDerm, Vivex Biologics, HemaClear, Tissue Regenix, NXTSTIM, and Sun Scientific. Its catalog spans orthopedics, soft tissue repair, wound care, foot and ankle, spine, cardiothoracic, pain management, plastic surgery, and dermatology applications.
The company's go-to-market is enterprise field sales targeting two primary segments: military and VA Hospitals accessed through federal procurement vehicles (VA SAC Award FSS 36F79725D0037 and DAPA agreements SP0200-18-H-0012 and SP0200-25-H-0003), and private healthcare providers served through direct physician and surgeon relationships and prime vendor partnerships with Owens & Minor, Medline, and Cardinal Health. Revenue is generated through one-time sale and distribution of biologics and medical devices on a quote-based pricing model with no public disclosure of unit economics or contract values.
RegeniSource holds SBA-certified SDVOSB and VOSB status, maintains EIN 81-4917236, CAGE 7SJF8, DUNS 080511300, and operates under NAICS codes covering pharmaceutical, medical device, and wholesale distribution. The business is privately held as an LLC with no disclosed institutional investors, parent company, or subsidiary structure. Operating geography is domestic US with concentration in the South Central region; there is no claimed global footprint. No AI/ML capabilities, APIs, or digital product surface are present — the company's competitive position rests on regulatory credentials, manufacturer breadth, and distribution access rather than technology differentiation.
RegeniSource firmographics
Firmographics- Name
- RegeniSource
- Legal name
- RegeniSource, LLC
- Website
- https://regenisource.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- RegeniSource is a Service Disabled Veteran Owned Small Business (SDVOSB) medical implant distributor in San Antonio, TX, distributing regenerative biologics and medical devices from ten-plus manufacturers to military, VA hospitals, and private healthcare providers.
- Ownership category
- akta.pro rank
RegeniSource industry classification
Industry- Product category
- Medical Device Distribution
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Biological Products, (No Disgnostic Substances) (2836), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM) (HLAHAEAG)
- akta.pro secondary industries
- Cartilage, Bone & Musculoskeletal Regeneration (HLAAAGAH), Cardiovascular & Vascular Regeneration (vascular grafts, angiogenesis) (HLAAAGAJ), Dental Implant Surgery & Bone Grafting (HLABAEAB)
Keywords
Where RegeniSource is headquartered
LocationHeadquarters
- HQ city
- San Antonio
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
RegeniSource business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Medical Implant Distribution: RegeniSource distributes regenerative medicine products including biologics, autologous products, and medical devices to healthcare providers. Revenue is generated through the sale and distribution of medical implants and biologics to military, VA Hospitals, and private sector healthcare partners.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels2 records
RegeniSource product offering
Product offeringCore offering
RegeniSource is a medical implant distributor that sells regenerative biologics, autologous products, and medical devices to healthcare providers. The company distributes an allograft bone, platelet-rich plasma (PRP), bone marrow concentrate (BMC), fish skin grafts, amniotic allografts, and wound care matrices from multiple manufacturers to military, VA Hospitals, and private healthcare partners.
Product overview
RegeniSource is a Service Disabled Veteran Owned Small Business (SDVOSB) medical implant distributor based in San Antonio, TX, focused on providing next-generation regenerative therapies. The company operates as a distributor of biologics, autologous products, and medical devices rather than as a product developer. Their product portfolio spans multiple therapeutic categories and manufacturers: CellRight Technologies (bone allograft products including ConCelltrate 100, Matrix OI, Matrix OI FlexIT, MatrixCellect 100 DBM Putty and Crunch); EmCyte Corporation (platelet rich plasma and bone marrow concentrate systems including AbsolutePRP/BMC, PROGENIKINE, PureBMC, PurePRP II and SupraPhysiologic variants); HemaClear (sterile surgical tourniquet); Kerecis (fish skin-based wound care and soft tissue products including MariGen, SurgiBind, SurgiClose); PainTEQ (LinQ SI joint therapy system); RenovoDerm (electrospun synthetic wound matrices including Anthem and Phoenix Wound Care Matrix); Sun Scientific (wound care compression and dressing systems); Tissue Regenix (DermaPure decellularized dermal graft); and Vivex Biologics (amniotic allografts including Cygnus, MiAmnion, VIA Disc NP, Viagenex). The company serves orthopedics, soft tissue repair, wound care, foot and ankle, spine, cardiothoracic, pain management, plastic surgery, dermatology, and aesthetics applications, primarily targeting military, VA hospitals, and private healthcare partners.
Differentiator
Problem solved
Functional benefit
Products and services
- ConCelltrate 100 100% human allograft bone product distributed by RegeniSource from CellRight Technologies for orthopedic and surgical applications.
- Matrix OI Compressible Stem Cell Containment matrix derived from 100% human bone, distributed by RegeniSource from CellRight Technologies.
- Matrix OI FlexIT Thin pliable cortical sheet that can be sized with scissors or scalpel when hydrated, distributed by RegeniSource from CellRight Technologies.
- MatrixCellect 100 DBM Putty DBM putty derived from 100% allograft bone, distributed by RegeniSource from CellRight Technologies.
- MatrixCellect 100 DBM Crunch DBM Crunch processed using CellRight Technologies proprietary demineralization process, histologically proven to exhibit five elements of bone formation post-sterilization.
- AbsolutePRP/BMC GenesisCS Component Concentrating System distributed by RegeniSource from EmCyte Corporation for platelet rich plasma and bone marrow concentrate preparation.
- PROGENIKINE Adipose Derived Stem Cells Adipose concentrating system that purifies, emulsifies, and condenses adipose treatment samples while removing inflammatory oil and infranatant contaminants, distributed by RegeniSource from EmCyte Corporation.
- PureBMC Bone marrow cell concentrate solution distributed by RegeniSource from EmCyte Corporation.
- PurePRP II Platelet rich plasma preparation that enhances monocyte concentrations while giving the end user control over the amount of neutrophils added to the PRP preparation, distributed by RegeniSource from EmCyte Corporation.
- HemaClear Sterile surgical tourniquet combining superior exsanguination, a large sterile surgical field, and blocking of arterial blood re-entry, distributed by RegeniSource.
- MariGen Intact fish skin used to support tissue regeneration and healing of chronic wounds, distributed by RegeniSource as part of the Kerecis Omega3 product line.
- SurgiBind FDA-approved medical device for soft tissue reinforcement using intact fish skin, distributed by RegeniSource as part of the Kerecis Omega3 product line.
- SurgiClose Intact fish skin used for regenerating tissue on surgical, traumatic and acute wounds, distributed by RegeniSource as part of the Kerecis Omega3 product line.
- LinQ Minimally invasive procedure system treating low back pain caused by SI joint dysfunction, distributed by RegeniSource from PainTEQ.
- Anthem Wound Care Matrix Sterile, single-use, conformable non-woven fibrous 3D matrix device for wound management, distributed by RegeniSource from RenovoDerm.
- Phoenix Wound Care Matrix Innovative 3D electrospun synthetic technology designed to inspire a pro-healing wound environment to restore the body's natural wound healing process, distributed by RegeniSource from RenovoDerm.
- Sun Scientific AeroCare System Wound care system including AeroCare VLU treatment, UnnaCare wound dressings, AeroBolster Foam dressings, ExuCare drainage management, and Aero-Wrap compression therapy, distributed by RegeniSource from Sun Scientific.
- DermaPure Decellularized Dermal Graft intended to provide reinforcement, repair, or replacement of damaged or inadequate integumental tissue, distributed by RegeniSource from Tissue Regenix.
- Cygnus Amniotic allografts providing immune-privileged anatomical barriers with mechanical protection for traumatized tissue while retaining preserved endogenous growth factors, cytokines and extracellular matrix proteins, distributed by RegeniSource from Vivex Biologics.
- MiAmnion Family of amnion patch allografts that may be used as an anatomical barrier in numerous clinical applications, distributed by RegeniSource from Vivex Biologics.
- VIA Disc NP Allograft intended to supplement degenerated intervertebral discs, distributed by RegeniSource from Vivex Biologics.
- Viagenex Family of amniotic allografts processed to retain the inherent mechanical properties of amniotic tissue and rich supply of extracellular matrix, growth factors and cytokines, distributed by RegeniSource from Vivex Biologics.
Companies that use RegeniSource
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles2 records
RegeniSource technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
RegeniSource partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and minor.
- CellRight TechnologiescoreRegeniSource distributes CellRight Technologies products including ConCelltrate 100, Matrix OI, Matrix OI FlexIT, and MatrixCellect DBM products. CellRight Technologies' vision is to establish Tissue Regenix Group as a leader in the science and innovation of regenerative medicine, committed to transforming patient care and delivering favorable healthcare outcomes.
- EmCyte CorporationcoreRegeniSource distributes EmCyte Corporation products including PurePRP II, PurePRP SupraPhysiologic, PureBMC, PureBMC SupraPhysiologic, AbsolutePRP/BMC, and Progenikine Adipose Derived Stem Cells. EmCyte's mission is to commit to the continual development and improvement of devices used for autologous regenerative biologics and to the promotion of autologous therapies used to enhance quality of life.
- KereciscoreRegeniSource distributes Kerecis products including MariGen, SurgiBind, and SurgiClose. Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding cellular therapy and infection control markets. FDA-approved medical devices for wound healing and soft tissue reinforcement.
- NXTSTIMminorRegeniSource distributes NXTSTIM EcoAI products customized for health and wellness journeys including pain relief, strength and rehabilitation, and muscle relaxation.
- PainTEQcoreRegeniSource distributes PainTEQ's LinQ therapy system, a minimally invasive procedure for treating low back pain caused by SI joint dysfunction. PainTEQ was built to bring interventional procedures to the market, working with pain management specialists to help reduce and eliminate SI joint dysfunction.
- RenovoDermcoreRegeniSource distributes RenovoDerm products including Anthem Wound Care Matrix and Phoenix Wound Care Matrix. RenovoDerm introduced a cutting-edge, multi-dimensional wound healing solution using 3D electrospun synthetic polymer matrix designed to improve wound healing outcomes by addressing chronicity and persistent inflammation.
- Vivex BiologicscoreRegeniSource distributes Vivex Biologics products including Cygnus amniotic allografts, MiAmnion amnion patch allografts, VIA Disc NP, and Viagenex amniotic allografts. Vivex's mission is to provide advanced regenerative product solutions that help patients suffering from musculoskeletal injuries, wounds, and burned skin.
- HemaClearcoreRegeniSource distributes HemaClear, an innovative all-in-one sterile surgical tourniquet device that combines superior exsanguination, a large sterile surgical field, and blocking of arterial blood re-entry.
- Tissue RegenixcoreRegeniSource distributes Tissue Regenix products including DermaPure, a decellularized dermal graft intended to provide reinforcement, repair, or replacement of damaged or inadequate integumental tissue.
- Sun ScientificminorRegeniSource distributes Sun Scientific products for wound care including AeroCare VLU treatment system, UnnaCare wound dressings, AeroBolster Foam dressings, ExuCare drainage management, and Aero-Wrap compression therapy products.
Scale indicators2 records
Recent moves5 records
Expansion highlights4 records
RegeniSource competitors and assessment
Company assessmentBroad incumbents
- McKesson Medical-Surgical: Largest U.S. medical-surgical distributor with deep federal (VA/DoD) contracts. Comparable as a broad incumbent in the same distribution and federal procurement ecosystem.
- Medline Industries: Largest privately-held medical manufacturer and distributor in the U.S. Stated RegeniSource prime vendor and direct competitor in medical/surgical distribution.
- Owens & Minor: One of the largest U.S. medical product distributors and a stated prime vendor partner of RegeniSource. Overlaps in federal healthcare supply and broad medical/surgical product distribution.
- Cardinal Health: Major medical distributor and a stated RegeniSource prime vendor. Operates in the same medical/surgical and federal procurement channels.
- Henry Schein: Large medical and dental distributor with specialty physician office and ambulatory surgery reach. Overlaps with RegeniSource in physician-channel distribution of regenerative and surgical products.
- Integra LifeSciences: Specialty medical device company with significant orthobiologics and wound care franchises. Comparable in regenerative medicine category participation but operates as a manufacturer rather than distributor.
Direct peers
- Concordance Healthcare Solutions: Specialty medical/surgical distributor serving hospitals, GPOs, and federal customers. Directly comparable to RegeniSource as a multi-line medical products distributor with overlapping orthopedic, wound care, and surgical supply categories.
- NDC (National Distribution & Contracting): Independent medical/surgical distributor serving physicians, surgery centers, and federal customers. Comparable scale and channel mix to RegeniSource, including GPO and VA-channel access.
- VGM Group: Healthcare distribution and member services network with strong presence in VA, federal, and post-acute channels. Similar GTM and customer overlap to RegeniSource.
Emerging players
- MiMedx: Regenerative medicine company focused on amniotic and placental tissue allografts. Competitively adjacent in the same product categories (amniotic allografts, wound care) that RegeniSource distributes through partners like Vivex.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
RegeniSource social profiles
Digital presenceRegeniSource financial estimates
Financial estimateRevenue estimate
Valuation estimate
RegeniSource leadership team
Management profileNumber of profiles
Profiles1 record
RegeniSource funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
RegeniSource M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about RegeniSource
What does RegeniSource do?
RegeniSource is a medical implant distributor that sells regenerative biologics, autologous products, and medical devices to healthcare providers. The company distributes an allograft bone, platelet-rich plasma (PRP), bone marrow concentrate (BMC), fish skin grafts, amniotic allografts, and wound care matrices from multiple manufacturers to military, VA Hospitals, and private healthcare partners.
Is RegeniSource a public or private company?
RegeniSource is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was RegeniSource founded?
RegeniSource was founded in -1. It employs 11 to 50 people.
Where is RegeniSource based?
RegeniSource is headquartered in San Antonio, United States, in the North America region.
How does RegeniSource make money?
One revenue line is on record: medical Implant Distribution.
Who are RegeniSource's main competitors?
Broad incumbents on record are McKesson Medical-Surgical, Medline Industries, Owens & Minor, Cardinal Health, Henry Schein and Integra LifeSciences. Direct peers are Concordance Healthcare Solutions, NDC (National Distribution & Contracting) and VGM Group. MiMedx is listed as an emerging player.
Does RegeniSource have an API?
No public API is recorded for RegeniSource.
What industry is RegeniSource in?
RegeniSource's product category is Medical Device Distribution. Its primary akta.pro industry code is HLAHAEAG, Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM), with a secondary code of HLAAAGAH, Cartilage, Bone & Musculoskeletal Regeneration. Its NAICS code is 325414 and its SIC code is 5047.